Preventing clonal evolutionary processes in cancer: Insights from mathematical models
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventing clonal evolutionary processes in cancer: Insights from mathematical models
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 29, Pages 8843-8850
Publisher
Proceedings of the National Academy of Sciences
Online
2015-07-21
DOI
10.1073/pnas.1501730112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stochastic modeling indicates that aging and somatic evolution in the hematopoietic system are driven by non-cell-autonomous processes
- (2016) Andrii I. Rozhok et al. Aging-US
- TERTpromoter mutations and telomerase reactivation in urothelial cancer
- (2015) Sumit Borah et al. SCIENCE
- Variation in cancer risk among tissues can be explained by the number of stem cell divisions
- (2015) C. Tomasetti et al. SCIENCE
- Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib
- (2014) D. Wodarz et al. BLOOD
- Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
- (2014) J. A. Woyach et al. BLOOD
- Cancer-Associated Mutations in Healthy Individuals: Assessing the Risk of Carcinogenesis
- (2014) Ignacio A. Rodriguez-Brenes et al. CANCER RESEARCH
- Kinase inhibitors overachieve in CLL
- (2014) Ken Garber NATURE REVIEWS DRUG DISCOVERY
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)
- (2014) N. L. Komarova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Minimizing the risk of cancer: tissue architecture and cellular replication limits
- (2013) I. A. Rodriguez-Brenes et al. Journal of the Royal Society Interface
- Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
- (2013) Jan A. Burger et al. LEUKEMIA & LYMPHOMA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Chromosomal translocations among the healthy human population: implications in oncogenesis
- (2012) Mridula Nambiar et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape
- (2012) Jan A. Burger CURRENT OPINION IN ONCOLOGY
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL
- (2011) C. Fazi et al. BLOOD
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia
- (2011) Yoshikane Kikushige et al. CANCER CELL
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- Targeting telomerase-expressing cancer cells
- (2011) Michel M. Ouellette et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- How does DNA break during chromosomal translocations?
- (2011) M. Nambiar et al. NUCLEIC ACIDS RESEARCH
- Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
- (2010) T D Shanafelt et al. LEUKEMIA
- Quantitative theory of telomere length regulation and cellular senescence
- (2010) I. A. Rodriguez-Brenes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- (2009) F. C. Guibal et al. BLOOD
- Paradoxical Dependencies of Tumor Dormancy and Progression on Basic Cell Kinetics
- (2009) H. Enderling et al. CANCER RESEARCH
- The longest telomeres: a general signature of adult stem cell compartments
- (2008) I. Flores et al. GENES & DEVELOPMENT
- Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
- (2008) M A Shammas et al. LEUKEMIA
- Age-specific incidence of cancer: Phases, transitions, and biological implications
- (2008) R. Meza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor size and detection in breast cancer: Self-examination and clinical breast examination are at their limit
- (2008) Uwe Güth et al. Cancer Detection and Prevention
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started